Sherman Darren sold $58K of OBIO
Sherman Darren (See Remarks) sold 15,000 shares of Orchestra BioMed Holdings, Inc. (OBIO) at $3.87 on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the reported open-market sale amount and price, executed under a pre-arranged 10b5-1 plan.
Market read
Traders may note the insider sale for sentiment, but there is no new fundamental catalyst in the filing text.
What to watch
The filing does not state any change in business outlook, and the text provides only the sale details, not context like option exercises, tax planning, or total compensation mix.
Background
The article is an SEC Form 4 insider transaction disclosure for Orchestra BioMed Holdings, Inc.
Ticker impact
Orchestra BioMed Holdings disclosed an officer/director open-market sale of 15,000 shares at $3.87 on a 10b5-1 plan.
Likely minimal immediate price impact; any effect is more about sentiment than new company information.
Form 4 reports a completed sale with no accompanying operational, financial, or regulatory disclosure in the text, and explicitly notes a pre-arranged 10b5-1 plan.
Market effects
No sector-wide implications; this is company-specific insider transaction reporting.
None indicated.
None indicated.
Counterpoint
10b5-1 sales can be purely mechanical liquidity events, so the market may overreact if it treats the sale as a bearish signal.
Key entities
- issuerOrchestra BioMed Holdings, Inc.
Subject of the Form 4 insider transaction disclosure (OBIO).
- insiderSherman Darren
Officer and director who sold 15,000 shares on 2026-06-01 under a 10b5-1 plan.